嘉实上证科创板生物医药ETF发起联接A(021060)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2026-03-30 |
23,865,617.48 |
32,736,452.32 |
14,376,868.02 |
5,506,033.18 |
| 2025-12-30 |
21,381,719.18 |
23,865,617.48 |
7,449,904.82 |
4,966,006.52 |
| 2025-09-29 |
17,241,955.85 |
21,381,719.18 |
12,180,946.25 |
8,041,182.92 |
| 2025-06-29 |
41,046,975.59 |
17,241,955.85 |
31,976,651.51 |
55,781,671.25 |
| 2025-03-30 |
15,244,146.11 |
41,046,975.59 |
29,528,147.11 |
3,725,317.63 |
| 2024-12-30 |
10,322,936.49 |
15,244,146.11 |
7,902,477.45 |
2,981,267.83 |
| 2024-09-29 |
10,041,165.18 |
10,322,936.49 |
344,462.19 |
62,690.88 |
微信公众号
证券之星APP
基本资料
